Literature DB >> 10835288

Duration of the hemodynamic effects of N(G)-nitro-L-arginine methyl ester in vivo.

E M Conner1, S Aiko, M Fernandez, H D Battarbee, L Gray, M B Grisham.   

Abstract

The objective of this study was to quantify the duration of the hemodynamic activity of N(G)-nitro-l-arginine methyl ester (l-NAME) in a variety of different tissues following a single bolus injection of this nitric oxide synthase inhibitor to healthy rats. l-NAME (15 micromol x kg(-1)) was injected (ip) into rats to produce maximal inhibition of endothelial cell NOS. Animals were subsequently anesthetized and blood flow was quantified using the radioactive microsphere/reference organ technique. At 1 h following a single bolus injection of l-NAME blood flow was reduced to the entire gastrointestinal tract, pancreas, and liver. Three hours following l-NAME administration, blood flow to the stomach and upper small intestine had returned to pretreatment levels; however, blood flow to the jejunum, ileal-jejunal junction, and colon remained significantly reduced. Splenic blood flow was significantly reduced and hepatic arterial blood flow was further reduced at this time as well. After 6 h following l-NAME administration, blood flow in all organs had completely recovered to control levels. Although cardiac index and total peripheral resistance had also returned to preinjection values at this time, mean arterial pressure remained elevated at 6 h posttreatment. Blood flow to the brain, lungs, and psoas muscle were unaffected by l-NAME administration at any time point. Taken together, these data demonstrate a differential regulation of vascular tone by NO in different vascular beds and, depending upon the organ system in question, the vasoactive activity of l-NAME may last from 3 to 6 h following a single bolus injection of this NOS inhibitor. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835288     DOI: 10.1006/niox.2000.0270

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  6 in total

Review 1.  Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

Authors:  Iurii Koboziev; Fridrik Karlsson; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2011-02-10       Impact factor: 5.325

2.  Induction of nitric oxide synthase in Anopheles stephensi by Plasmodium falciparum: mechanism of signaling and the role of parasite glycosylphosphatidylinositols.

Authors:  Junghwa Lim; D Channe Gowda; Gowdahalli Krishnegowda; Shirley Luckhart
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 3.  Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury.

Authors:  Yuta Abe; Ian Hines; Gazi Zibari; Matthew B Grisham
Journal:  Arch Biochem Biophys       Date:  2008-10-12       Impact factor: 4.013

4.  Divergent roles of superoxide and nitric oxide in liver ischemia and reperfusion injury.

Authors:  Ian N Hines; Matthew B Grisham
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

5.  Interactions between renal vascular resistance and endothelium-derived hyperpolarization in hypertensive rats in vivo.

Authors:  Søs U Stannov; Jens Christian Brasen; Max Salomonsson; Niels-Henrik Holstein-Rathlou; Charlotte M Sorensen
Journal:  Physiol Rep       Date:  2019-08

6.  Mammalian transforming growth factor beta1 activated after ingestion by Anopheles stephensi modulates mosquito immunity.

Authors:  Shirley Luckhart; Andrea L Crampton; Ruben Zamora; Matthew J Lieber; Patricia C Dos Santos; Tina M L Peterson; Nicole Emmith; Junghwa Lim; David A Wink; Yoram Vodovotz
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.